Uridine triacetate Triacetyluridine 4105-38-8 CAS NO.4105-38-8

Uridine triacetate Triacetyluridine 4105-38-8

On September 4, 2015, the FDA approved Wellstat's new molecular solid drug, Uridine Triacetate, on the market for oral granules called Xuriden. Used to treat congenital hyperuricemia, a rare form of hereditary whey aciduria, granted orphan drugs and priority review qualifications. Ureaside triacetate is a substitute for urea, urea can promote the body whey acid into urea, thus avoiding the large number of whey acid in the blood and urine.
Bioactive
Uridine triacetate (Vistonuridine, PN401) is an oral active precursor drug for the natural product nucleoside urea. It is used in the treatment of hereditary whey aciduria or in emergency treatments such as fluorouracil, capetamine overdose or toxicity.

Our advantages: 

1, High quality with competitive price:

1) Standard:BP/USP/EP/Enterprise standard

2) All Purity≥99%

3) We are manufacturer and can provide high quality products with factory price.

 2, Fast and safe delivery

1) Parcel can be sent out in 24 hours after payment.Tracking number available

2) Secure and discreet shipment.Various transportation methods for your choice.

3) Customs pass rate ≥99%

4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,

and we have stock in there for transferring.